1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Roche Holding AG
  6. News
  7. Summary
    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
Delayed Swiss Exchange  -  05/25 12:48:59 pm EDT
333.00 CHF   +0.47%
12:51pRoche's Polivy Receives EU Approval for Lymphoma Treatment
MT
12:37pRoche develops test kits to detect monkeypox virus
RE
12:16pRoche Develops PCR Tests to Detect Monkeypox Virus
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Roche Shareholders OK $21 Billion Repurchase Deal With Novartis

11/26/2021 | 05:31am EDT


© MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
NOVARTIS AG 0.16% 87.82 Delayed Quote.9.22%
ROCHE HOLDING AG 0.47% 333 Delayed Quote.-12.57%
All news about ROCHE HOLDING AG
12:51pRoche's Polivy Receives EU Approval for Lymphoma Treatment
MT
12:37pRoche develops test kits to detect monkeypox virus
RE
12:16pRoche Develops PCR Tests to Detect Monkeypox Virus
DJ
12:15pCORRECTION : Roche Develops PCR Tests for Monkeypox Virus Research
MT
12:13pRoche Develops PCR Tests for Monkeypox Virus Research
MT
12:11pRoche develops test kits to detect monkeypox virus
RE
11:48aRoche's Polivy combination approved by European Commission for people with previously u..
AQ
11:45aRoche develops unique PCR tests to detect the monkeypox virus
AQ
10:47aAlembic Pharmaceuticals receives USFDA Final Approval for Pirfenidone Tablets, 267 mg a..
AQ
05/24GLOBAL MARKETS LIVE : Broadcom, Airbnb, Roche, Toyota, Uber
More news
Analyst Recommendations on ROCHE HOLDING AG
More recommendations
Financials
Sales 2022 63 642 M 66 301 M 66 301 M
Net income 2022 14 819 M 15 438 M 15 438 M
Net Debt 2022 10 926 M 11 383 M 11 383 M
P/E ratio 2022 17,7x
Yield 2022 2,93%
Capitalization 271 B 282 B 283 B
EV / Sales 2022 4,43x
EV / Sales 2023 4,26x
Nbr of Employees 100 920
Free-Float 82,4%
Chart ROCHE HOLDING AG
Duration : Period :
Roche Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROCHE HOLDING AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 331,45 CHF
Average target price 393,49 CHF
Spread / Average Target 18,7%
EPS Revisions
Managers and Directors
Severin Schwan Chief Executive Officer & Executive Director
Alan Hippe Chief Financial & Information Officer
Christoph Franz Chairman
Levi A. Garraway Chief Medical Officer
Pascale Schmidt Chief Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
ROCHE HOLDING AG-12.57%281 309
JOHNSON & JOHNSON6.04%477 336
PFIZER, INC.-9.55%299 678
ELI LILLY AND COMPANY10.77%275 413
ABBVIE INC.10.13%263 494
NOVO NORDISK A/S1.61%244 637